Evidence map›Paper›PMID 41146787›Full record

ArticleCureus2025

Permissive Hypoxemia With Partial Pressure of Oxygen in Arterial Blood (PaO2) at Less Than 50 mmHg: A Case of Successful Ventilator Weaning for COVID-19-Associated Acute Respiratory Failure.

Hiroshi Adachi, Kwonil Choi, Motohiro Shimizu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiroshi AdachiIntensive Care Department, Ryokusenkai Yonemori Hospital, Kagoshima, JPN.
Kwonil ChoiIntensive Care Department, Ryokusenkai Yonemori Hospital, Kagoshima, JPN.
Motohiro ShimizuIntensive Care Department, Ryokusenkai Yonemori Hospital, Kagoshima, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Permissive hypoxemia is a ventilation strategy that intentionally tolerates mild to moderate hypoxemia to minimize lung injury. Unlike conventional management, which aims for normal oxygen levels, permissive hypoxemia maintains a partial pressure of oxygen in arterial blood (PaO2) of 55-60 mmHg and an arterial oxygen saturation (SaO2) of 88-92%. This approach ensures sufficient oxygen delivery for vital functions while reducing mechanical stress on the lungs from high oxygen concentrations and airway pressures, which can lead to lung injury. This flexible, individualized strategy prioritizes lung protection over achieving absolute oxygenation values. A woman in her 70s, with COVID-19-associated pneumonia, was admitted with severe acute respiratory failure and required mechanical ventilation. Despite a lung-protective ventilation strategy, her oxygenation remained poor. A permissive hypoxemia strategy was reluctantly initiated, which allowed her PaO2 to drop below 50 mmHg. Under strict monitoring of her symptoms, vital signs, and lactate levels, she was successfully weaned from mechanical ventilation without her respiratory status or other organ systems worsening. The patient was discharged home walking approximately three weeks after admission, with no other complications. To our knowledge, few reports have described an adult patient who successfully tolerated a PaO₂ below 50 mmHg. This case underscores the importance of a rigorous selection of patients and a comprehensive assessment of their overall condition. It demonstrates that a personalized approach, rather than simply adhering to a high oxygenation target, can lead to successful outcomes in severe respiratory failure, affirming that cautious and well-considered attempts in challenging cases are worthwhile.

Indexed as

covid-19 associated acute respiratory failureindividualized managementlung-protective ventilationpermissive hypoxemiarefractory hypoxemia

Identifiers

PMID41146787
PMCPMC12553533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.